Rapid Therapeutic Science Laboratories, Inc. (RTSL)
OTCMKTS: RTSL · Delayed Price · USD
0.0050
0.00 (0.00%)
Apr 10, 2024, 11:09 AM EDT - Market closed
Company Description
Rapid Therapeutic Science Laboratories, Inc. operates as a biotech company, provides natural based relief through aerosol delivery systems for non-psychoactive cannabinoids.
The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020.
Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013 and is based in Dallas, Texas.
Rapid Therapeutic Science Laboratories, Inc.
| Country | United States |
| Founded | 2013 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 3 |
| CEO | Donal R. Schmidt Jr. |
Contact Details
Address: 558 County Road 472 De Leon, Texas 76444 United States | |
| Phone | 800-497-6059 |
Stock Details
| Ticker Symbol | RTSL |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001575659 |
| CUSIP Number | 753431105 |
| ISIN Number | US7534312043 |
| Employer ID | 46-2111820 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Donal R. Schmidt Jr. | President, Chief Executive Officer and Chairman |
| D. Hughes Watler Jr. | Chief Financial Officer and Director |
| Dr. Duane C. Drinkwine Ph.D. | Chief Science Officer |
| Ryan C. Johnson | Vice President of Marketing |
| Frank Gill | Chief Isolate Laboratory Technician |
| Sean Paul Berrier | Senior Vice President |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Jan 16, 2024 | 15-12G | Securities registration termination |
| Dec 6, 2023 | 8-K | Current Report |
| Nov 13, 2023 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| Aug 23, 2023 | 8-K | Current Report |
| Aug 14, 2023 | 10-Q | Quarterly Report |
| Jul 14, 2023 | 8-K | Current Report |
| May 17, 2023 | RW | Filing |
| May 12, 2023 | 10-Q | Quarterly Report |
| Mar 30, 2023 | 10-K | Annual Report |